![Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology | Journal of Clinical Oncology Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2017/jco.2017.35.issue-12/jco.2016.71.5292/20171009/images/large/jco.2016.71.5292t1.jpeg)
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology | Journal of Clinical Oncology
Mary Ann Watson - Professor, Director of LearnOn - Metropolitan State University of Denver | LinkedIn
![Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients | British Journal of Cancer Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01608-2/MediaObjects/41416_2021_1608_Fig1_HTML.png)
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients | British Journal of Cancer
![Genomics and Personalized Medicine: What Everyone Needs to Know® by Michael Snyder | eBook | Barnes & Noble® Genomics and Personalized Medicine: What Everyone Needs to Know® by Michael Snyder | eBook | Barnes & Noble®](http://prodimage.images-bn.com/pimages/9780190234799_p0_v2_s1200x630.jpg)